Načítá se...
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against osteosarcoma
Recent studies have identified that constitutively active phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling is an important feature of osteosarcoma, where it promotes cell proliferation, survival, and chemo-resistance. Here, we studied the therapeutic potential...
Uloženo v:
Vydáno v: | Cancer Biol Ther |
---|---|
Hlavní autoři: | , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Taylor & Francis
2015
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622008/ https://ncbi.nlm.nih.gov/pubmed/25869769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1017155 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|